IMM Investment

IMM Investment is an independent asset management firm based in Seoul, South Korea, established in 1999. The firm specializes in venture capital, mezzanine financing, and infrastructure investments, primarily targeting small and medium-sized enterprises in the information technology, healthcare, biotechnology, and manufacturing sectors. With a strong foundation of trust from institutional investors, IMM Investment focuses on creating significant value for its portfolio companies through strategic investments and partnerships.

Hyun-Chan Cho

Managing Partner

Jaeyong Cho

Senior Managing Director

Younghwan Chung

Principal, Growth Capital

Jeanrok Han

Managing Director

Chong Kang

Managing Director

Suyoung Kim

Managing Director

Meenjoo Kim

Investment Professional

Minjeong Kim

Venture Capitalist

Hyejin Kim

Managing Director

Jaeyun Koo

Senior Managing Director and Division Head

Jean Lee

Managing Director

Young Lee

Vice President

Da Lee

Director

YoungJoon Lee

Co-CEO and Managing Partner

Aleum Lee

Managing Director

Philip Li

Managing Director

Sungmin Na

Senior Managing Director and Division Head

Jinheum Paek Ph.D

Senior Managing Director

Wonki Yoon

Senior Managing Director and Division Head

Yeojung Moon Ph.D

Senior Managing Director and Division Head

Byeonggyu Kim Ph.D

Managing Director

Jiyun Jung Ph.D

Managing Director

Past deals in South Korea

CLO Virtual Fashion

Series C in 2024
CLO Virtual Fashion Inc. specializes in three-dimensional (3D) visualization technologies tailored for the fashion industry. Founded in 2009 and headquartered in Seoul, South Korea, with an additional office in Munich, Germany, the company offers CLO3D, a software solution for garment simulation, and CLO Innovation, an enterprise tool aimed at optimizing interdepartmental processes through 3D technology. Its product range includes CLO, designed for apparel designers; Marvelous Designer, which serves character artists in gaming and animation; and Benefit by CLO, a virtual fitting platform. CLO Virtual Fashion aims to transform the fashion communication landscape by facilitating collaboration among teams involved in the digital product lifecycle, thereby reducing lead times while preserving the intricacies of garment design. The company envisions its technology as a means to virtualize garments globally, providing valuable insights about designs and trends.

Medipixel

Series B in 2023
Medipixel, Inc., founded in 2017 and based in Seoul, South Korea, specializes in developing artificial intelligence-based diagnostic software and semi-autonomous surgical tools for lung cancer and cardiac disease interventions. The company employs a team of experts in computer vision, deep learning, and reinforcement learning, collaborating with leading healthcare institutions to enhance diagnostic and surgical processes. Medipixel offers several innovative solutions, including an AI-based diagnosis tool that assists doctors in identifying lesions during coronary angiography, a guide and planning solution that visualizes hidden coronary artery segments to facilitate guidewire manipulation, and an automated navigation engine that optimizes robotic control for surgical procedures. By integrating advanced AI technologies, Medipixel aims to improve the quality of medical care and patient outcomes in the field of surgery.

MangoBoost

Series A in 2023
MangoBoost is a provider of advanced system solutions maximizing AI data center efficiency. Central to our wide array of solutions, the MangoBoost DPU enables cost-efficient, standards-based AI infrastructure by providing full compatibility with all commodity GPUs, accelerators and storage products, effective utilization of legacy infrastructure and an easy-to-use network system. Founded in 2022 with 10 years of prior research published at top-tier conferences such as OSDI and ISCA, MangoBoost consists of more than 80 system architects, software engineers and FPGA/SoC engineers, many of whom hold a PhD from the world’s top research institutions and extensive industry experience at big techs. MangoBoost has secured more than 60 million US dollars in funding and is rapidly expanding its presence in the United States, Canada and South Korea.

PinotBio

Venture Round in 2023
PinotBio, Inc., based in Suwon, South Korea, is a biotechnology company focused on researching and developing small molecule drugs in the fields of ophthalmology and oncology. The company is engaged in pre-clinical trials for NTX-101, a treatment designed for glaucoma, as well as other technologies targeting anticancer therapies through epigenetics. PinotBio aims to create innovative treatments that assist in managing refractory and relapsed cancers, enhancing the ability of healthcare providers to treat patients with life-threatening conditions. Founded in 2017, the company is dedicated to addressing unmet medical needs in these critical areas.

Nextin

Venture Round in 2023
Nextin, Inc. is a South Korean company that focuses on manufacturing defect inspection and metrology systems tailored for the semiconductor and display industries. Founded in 2010 and headquartered in Hwaseong-si, the company specializes in advanced technology for defect detection. Its product lineup includes the AEGIS wafer inspection systems, which identify various defects such as bridges, thinning, protrusion, footing, scratches, and particles during semiconductor manufacturing processes. Additionally, Nextin offers the IRIS wafer metrology-inspection system, designed to measure vertical structures and detect pattern defects in advanced 3D semiconductor devices and TSV processing. The TWINS integration module is also part of their offerings, enabling measurement and inspection of edge trimming processes.

Medb Korea

Seed Round in 2023
Medb Korea is a medical consumer, hospital, and pharmacy-focused online medical care and prescription drug delivery platform.. Medb Korea is located in Gangnam-gu, Seoul.

ZigBang

Venture Round in 2022
ZigBang Co., Ltd. is a South Korean company founded in 2010, specializing in a property listing platform that connects real estate agents with renters. The company offers a user-friendly marketplace for apartment hunting through its mobile and web applications, allowing users to search for rental properties based on criteria such as the number of rooms, occupants, and price. ZigBang has reported approximately 6 million users, although this figure includes both active and inactive accounts. The platform aims to simplify the rental process and help users make informed choices while potentially saving money on housing.

My Franchise

Series B in 2022
My Franchise is a company founded in 2019 in Seoul, South Korea, that addresses the information gap between franchise headquarters and potential founders. It operates an online platform that facilitates connections between these two parties, optimizing their partnership potential. The platform offers valuable insights for prospective founders, including data on the number of franchisees by year, average sales figures, and start-up costs associated with domestic franchise brands. This allows users to effectively compare and analyze important brand information across various industries, enabling informed decision-making for franchise investments.

Neubility

Series A in 2022
Neubility is a company focused on transforming the delivery industry through the use of self-driving delivery robots. Founded in 2017 and headquartered in Seoul, the company utilizes advanced vision-based localization and path-planning technologies to operate autonomous delivery robots. This innovation aims to address the challenges of last-mile delivery, particularly in densely populated urban areas, by providing a reliable and cost-effective solution for businesses and consumers alike. Neubility's robots perform deliveries without human intervention, thereby redefining urban logistics and enhancing the efficiency of parcel delivery services.

Spark Biopharma

Series C in 2022
SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Dunamu

Venture Round in 2022
Dunamu Inc. is a South Korean company founded in 2012 that specializes in blockchain and securities services. It operates UPbit, a prominent global cryptocurrency exchange, as well as Stockplus, a securities information and trading platform, and U-Stockplus, an over-the-counter platform for private company trading. Additionally, Dunamu offers Luniverse, a blockchain-as-a-service solution, and Onboard, an equity management platform designed for private companies to manage shareholder equity electronically. The company's services are accessible through a mobile application, which provides users with real-time cryptocurrency prices and analytics, ensuring a secure and user-friendly trading experience across various markets.

Nearthlab

Series C in 2022
Nearthlab, Inc. is a technology-focused start-up based in Seoul, South Korea, specializing in the development of autonomous drone systems primarily for the wind and renewable energy sectors. Founded by graduates of KAIST, the company leverages proprietary deep-learning algorithms to enhance safety inspections. Its flagship products include NearthWIND Pro, an autonomous drone designed for wind turbine inspections that can detect cracks and damages using AI, Zoomable, a cloud-based platform for managing and analyzing inspection data, and NearthWIND Mobile, a mobile solution for autonomous flight control. Nearthlab's AI technology allows for efficient autonomous flight in low-computing power and low-latency conditions, significantly reducing inspection times from hours to minutes. The company is supported by prominent venture capital firms in Korea, positioning it as a leader in drone technology for inspection purposes.

Kukka

Series B in 2021
Kukka, Inc. is a South Korean company that specializes in flower sales for various settings, including office spaces, showrooms, and events. Established in 2014 and based in Seoul, Kukka offers a range of services, such as flower subscription, bouquet delivery, same-day delivery, and custom floral design. The company aims to promote the enjoyment of flowers in everyday life, reflecting Finnish cultural values. In addition to individual customer services, Kukka also provides corporate flower solutions and floral decoration for events. Customers can conveniently order fresh flowers online, and the company further engages with its clientele through flower art classes and related accessories.

Lunit

Venture Round in 2021
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company develops solutions for various medical imaging modalities, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. Lunit aims to enhance clinical decision-making for physicians by leveraging machine learning technology to provide accurate and consistent diagnoses. Its product offerings include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which includes AI-powered biomarkers for immuno-oncology. Lunit's deep learning technology has been recognized for its capabilities, ranking among the top in prestigious image recognition competitions, highlighting its innovative approach to processing medical imaging data and utilizing weakly labeled data for improved pattern recognition.

Crowdworks

Series C in 2021
CrowdWorks, Inc. operates an online crowdsourcing platform designed to enhance the artificial intelligence (AI) workflow by providing high-quality training data for machine learning applications. Based in Seoul, South Korea, the company specializes in collecting, strengthening, and structuring learning data for various forms, including images, text, voice, and survey responses. With a network of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-generated data, thereby accelerating the machine learning process. Its platform incorporates Auto-ML features, allowing AI development to be more efficient. Over 430 leading AI companies have utilized CrowdWorks' solutions to expedite the training and deployment of advanced AI services.

Dohands

Series B in 2021
Dohands Corporation is a logistics service provider based in Seoul, South Korea, specializing in customized solutions for e-commerce sellers. Founded in 2013, the company offers a range of services including overseas shipping, logistics consulting, inventory management, and tailored delivery options. Dohands focuses on short-term delivery, providing effective logistics alternatives for crowdfunding, pre-orders, and promotional activities, thereby enabling businesses to transport and deliver their products in a cost-efficient manner. Through its innovative approach, Dohands aims to simplify the logistics process for e-commerce companies.

Hugel Control

Post in 2021
Hugel, Inc. is a biopharmaceutical company based in Chuncheon-si, South Korea, specializing in the development and manufacturing of innovative medical products. The company offers a range of Botulinum Toxin products under various brand names, including Botulax and Hugel Toxin, for medical applications such as treating eyelid convulsions, severe wrinkles, upper limb stroke, and specific foot deformities in children. Additionally, Hugel produces hyaluronic acid fillers marketed under brands like Dermalax and Revigance, as well as cosmetics under the Wellage brand. The company is committed to enhancing global health and quality of life through advanced technology and creativity, operating manufacturing facilities in Shinbuk and Geodu. Founded in 2001, Hugel aims to expand its international presence in the biopharmaceutical sector.

Orum Therapeutics

Series B in 2021
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.

Soomgo

Series C in 2021
Soomgo, Inc. operates an on-demand online platform that connects customers in South Korea with local service professionals across a wide range of categories. Founded in 2014 and headquartered in Seoul, the company facilitates access to over 1,000 services, including music lessons, fitness training, academic tutoring, home services, event planning, wedding design, and beauty services. As the largest local service marketplace in South Korea, Soomgo aims to streamline the hiring process for users by enabling them to quickly and easily find and hire qualified professionals for their specific needs. The company is backed by prominent investors from both the United States and Korea, further bolstering its position in the market.

Trenbe

Series B in 2021
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Established in 2016, Trenbe has positioned itself in the footwear market while also offering a diverse range of fashion items. The company focuses on providing a convenient shopping experience for consumers through its online platform.

TCUBEit

Venture Round in 2021
TCUBEit Inc. is a biotechnology company based in Sejong, South Korea, with an additional location in Cheongju. Founded in 2019, TCUBEit specializes in T cell-based immunotherapy, focusing on the collection and organization of T cells from patients. The company is dedicated to enhancing both the quantity and quality of T cells, which play a crucial role in identifying and eliminating cancers and infections in the human body. Moreover, TCUBEit is involved in the research, development, and commercialization of T-cell receptor-based cellular therapeutics, facilitating the discovery of innovative personalized therapies for cancer treatment.

DeepNoid

Seed Round in 2020
DeepNoid Inc. specializes in medical artificial intelligence solutions, offering a wide range of products designed to analyze clinical data related to various diseases. The company's offerings include DEEP:NEURO, DEEP:LUNG, DEEP:SPINE, DEEP:CHEST, DEEP:BREAST, DEEP:ENDO, DEEP:DENTAL, DEEP:FUNDUS, DEEP:PATH, and DEEP:LIVER, which focus on processing medical images such as CT, MRI, and X-ray scans, as well as pathological images and electronic medical records. Founded in 2008 and based in Seoul, South Korea, DeepNoid operates as a doctor-driven platform that supports medical imaging AI model research. It provides users with access to both image processing and neural network modules at no cost, leveraging cloud computing resources for efficient operation.

HurayPositive

Series B in 2020
HurayPositive (휴레이포지티브) is a healthcare and wellness innovation-focused company based in Seoul, Korea. The company provides mHealth, PHR, PWR, and genome- and analysis-related healthcare and wellness services, as well as gamification, SNS consulting, user interface, and experience development-related IT convergence services. HurayPositive was established on April 6, 2010.

SolarConnect

Seed Round in 2020
SolarConnect, Inc. is a company based in Seoul, South Korea, specializing in solar energy and information technology-based energy solutions. Founded in 2016, SolarConnect operates solar energy plants and provides installation services for solar panels in residential buildings and apartments. The company's expertise encompasses both the solar and energy industries, focusing on delivering innovative financial and IT solutions to enhance energy efficiency and sustainability.

H2O Hospitality

Series B in 2020
H2O Hospitality, Ltd. is a leading hospitality management company operating in South Korea and Japan, specializing in hotel and vacation rental management services. Established in 2015 and based in Seoul, the company leverages technology to automate operational processes, significantly reducing fixed costs and enhancing efficiency. H2O Hospitality offers a comprehensive range of services, including profit management, housekeeping and facility management, customer call response, online marketing, and reservation management. Its proprietary property management system (PMS) enables seamless coordination between guests, accommodations, and housekeeping, facilitating smoother operations without the need for on-site staff. This innovative approach allows H2O to optimize customer attraction and streamline reservation management, thereby supporting property owners in effectively managing their rental facilities.

StyleShare

Series D in 2020
StyleShare Inc. is a mobile and web application developed for users to share and discover information related to fashion, beauty, and lifestyle. Founded in 2011 and based in Seoul, South Korea, the platform has attracted millions of users across 120 countries, establishing itself as a leading source for everyday fashion and beauty insights. Users can share their outfits, purchases, and receive updates, fostering a community centered around fashion discovery. StyleShare has received notable recognition from prominent publications such as VOGUE and Elle Japan, solidifying its status as a top mobile application in the fashion sector.

Lunit

Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company develops solutions for various medical imaging modalities, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. Lunit aims to enhance clinical decision-making for physicians by leveraging machine learning technology to provide accurate and consistent diagnoses. Its product offerings include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which includes AI-powered biomarkers for immuno-oncology. Lunit's deep learning technology has been recognized for its capabilities, ranking among the top in prestigious image recognition competitions, highlighting its innovative approach to processing medical imaging data and utilizing weakly labeled data for improved pattern recognition.

Trenbe

Series A in 2019
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Established in 2016, Trenbe has positioned itself in the footwear market while also offering a diverse range of fashion items. The company focuses on providing a convenient shopping experience for consumers through its online platform.

Orum Therapeutics

Series B in 2019
Orum Therapeutics is a private biotechnology company based in Daejeon, South Korea, founded in 2016. The company specializes in the research and development of therapeutic antibodies through its innovative cell-penetrating antibody platform, Oromab™. This platform is designed to target cytosolic proteins, addressing unmet medical needs in cancer and rare genetic diseases. Orum's unique approach allows for the intracellular delivery of active antibody therapeutics or payloads, enabling the inhibition of drug targets that have been previously considered undruggable by conventional small molecules or antibody therapies. Orum's technology is adaptable to various cell types and intracellular proteins without requiring chemical modifications, aiming to develop effective treatments with improved specificity and reduced toxicity.

Soomgo

Series B in 2019
Soomgo, Inc. operates an on-demand online platform that connects customers in South Korea with local service professionals across a wide range of categories. Founded in 2014 and headquartered in Seoul, the company facilitates access to over 1,000 services, including music lessons, fitness training, academic tutoring, home services, event planning, wedding design, and beauty services. As the largest local service marketplace in South Korea, Soomgo aims to streamline the hiring process for users by enabling them to quickly and easily find and hire qualified professionals for their specific needs. The company is backed by prominent investors from both the United States and Korea, further bolstering its position in the market.

GeneMedicine

Series A in 2019
GeneMedicine(GM) is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies, aiming to transform the therapeutic outcomes for cancer patients. Using their proprietary adenovirus platform, GM is developing several pipeline products that can be intratumorally and intravenously administered to selectively attack and eradicate tumor cells as well as potently stimulating multiple arms of antitumor immune response. GM’s viral immunotherapy has proven effective as both a standalone therapy and in combination with current standard of care, including immune checkpoint inhibitors (ICI). Intratumoral administration of GM oncolytic adenovirus offers several advantages over competitor products; (1) higher level of virus accumulation and localization in tumor tissues and (2) lower off-target systemic exposure, ultimately exerting potent therapeutic effect with minimal systemic toxicity. Our pipeline can effectively treat wide range of tumor types, including breast cancers (triple-negative and hormone receptor-positive), prostate cancer, melanoma, and non-melanoma skin cancer, desmoplastic cancers (like pancreatic cancer), and injectable visceral tumors that have spread to the liver, such as metastases from colorectal and lung cancer. To treat metastatic and recurrent cancers in late-stage cancer patients, GM has developed systemic delivery platform for oncolytic viruses that avoids rapid blood clearance and inactivation by the immune system and various blood components, which are known to severely hamper the clinical effectiveness of intravenously administered viral immunotherapies. Systemic delivery represents an important next step in successful oncolytic virus treatments for intractable and metastatic cancers that have disseminated to multiple organs. Headquartered in the Fusion Technology Center, Seoul, South Korea, GM is a leader in oncolytic immunotherapy. GM’s potent multi-armed oncolytic viral platform (GM-OAd) is a culmination of multiple proprietary oncolytic adenovirus technologies, which has been intelligently designed and carefully optimized to ensure maximum therapeutic benefit in patients. The company was founded in 2014 and has been the recipient of Korean venture backing and grants. GM-OAd is a proprietary oncolytic adenovirus that has been extensively engineered to maximize its safety, cancer selectivity, and anti-tumor activity. GM-OAd-mediated oncolysis results in immunogenic cell death to trigger robust antitumor immune activation and memory formation to ensure long-term therapeutic benefit against cancer. GM has a highly scalable, low cost manufacturable platform offering highly versatile, innovative treatment options for patients with advanced or metastatic tumors. Further, they have a deep portfolio of unique, globally protected, intellectual property including patents for systemic delivery platform for oncolytic virus and technologies that ensure effective degradation of tumor extracellular matrix to enhance the intratumoral permeation and distribution of other conventional cancer drugs, like chemotherapy, targeted antibodies, and ICI, to achieve strong synergistic potential. GeneMedicine is interested in assessing your interest in partnering their assets.

Trenbe

Series A in 2019
Trenbe Inc. is an e-commerce company based in Seoul, South Korea, specializing in the online sale of apparel, bags, shoes, and accessories for both men and women. Established in 2016, Trenbe has positioned itself in the footwear market while also offering a diverse range of fashion items. The company focuses on providing a convenient shopping experience for consumers through its online platform.

Creative and Innovative System

Venture Round in 2019
Creative and Innovative System Corporation specializes in the manufacture and sale of equipment for lithium-ion batteries, which are essential for various applications, including IT instruments and electric vehicles. Founded in 2002 and headquartered in Daegu, South Korea, the company provides a range of electrode manufacturing equipment, including coaters, roll presses, slitters, and tape laminators. Additionally, Creative and Innovative System is involved in supplying equipment for solar cell production. Its focus on innovative battery technology positions the company as a key player in the growing renewable energy and electric vehicle sectors.

Kbank

Series B in 2018
Kbank is the first digital-only bank in South Korea, operating an internet banking platform designed to facilitate digital funds transactions. The bank specializes in internet fund transfers and offers a range of services including handling deposits, loans, and credit cards. Additionally, Kbank provides wealth management products, enabling clients across the country to access convenient virtual banking solutions. Through its innovative approach, Kbank aims to simplify and enhance the banking experience for its customers.

OliPass

Venture Round in 2018
OliPass is a South Korea-based biotechnology company focused on enhancing quality of life through innovative life sciences solutions. The company develops its proprietary OliPass PNA platform, which integrates cationic lipid moieties onto nucleobases to create advanced therapeutic options. Its product pipeline includes treatments for various health conditions, such as injectable solutions, hypercholesterolemia, chemo and radio-sensitizers, and Type II diabetes. By collaborating on research and development, OliPass aims to transform perceptions of biotechnology and contribute to healthier living for individuals globally.

Bagelcode

Series C in 2018
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, that specializes in developing social casino games. Founded in 2012, the company has built a global presence, attracting over 170 members from various countries, including South Korea, the United States, and the United Kingdom. With more than 45 million users worldwide, Bagelcode focuses on creating an engaging gaming experience that allows players to enjoy casino games like slots and poker on both web and mobile platforms. The company emphasizes the importance of individual growth for collective success, fostering a diverse team of talented professionals from top universities and countries. Since its inception, Bagelcode has demonstrated substantial growth, launching multiple successful titles and continuously seeking new talent to achieve its goal of becoming a leading global gaming company.

StyleShare

Series C in 2018
StyleShare Inc. is a mobile and web application developed for users to share and discover information related to fashion, beauty, and lifestyle. Founded in 2011 and based in Seoul, South Korea, the platform has attracted millions of users across 120 countries, establishing itself as a leading source for everyday fashion and beauty insights. Users can share their outfits, purchases, and receive updates, fostering a community centered around fashion discovery. StyleShare has received notable recognition from prominent publications such as VOGUE and Elle Japan, solidifying its status as a top mobile application in the fashion sector.

Y-Biologics

Series C in 2018
Y-Biologics Inc. is a biotechnology company based in Daejeon, South Korea, specializing in the discovery and development of novel antibody therapeutics, particularly in the field of immuno-oncology. Established in 2007, the company has developed a unique bispecific antibody platform technology known as AliCE, which retains the structure of the parental antibody to ensure high binding affinity to cancer antigens. Additionally, Y-Biologics has created the Y-max ABL library, which comprises a diverse range of antibodies. The company also offers contract research services, further contributing to its position in the antibody drug market. Through its innovative technologies and research efforts, Y-Biologics aims to advance its portfolio of antibody drugs and strengthen its role in the global immuno-chemotherapeutic landscape.

Bagelcode

Series B in 2017
Bagelcode, Inc. is a mobile gaming company based in Seoul, South Korea, that specializes in developing social casino games. Founded in 2012, the company has built a global presence, attracting over 170 members from various countries, including South Korea, the United States, and the United Kingdom. With more than 45 million users worldwide, Bagelcode focuses on creating an engaging gaming experience that allows players to enjoy casino games like slots and poker on both web and mobile platforms. The company emphasizes the importance of individual growth for collective success, fostering a diverse team of talented professionals from top universities and countries. Since its inception, Bagelcode has demonstrated substantial growth, launching multiple successful titles and continuously seeking new talent to achieve its goal of becoming a leading global gaming company.

GLOWDAYZ

Series B in 2017
GLOWDAYZ is a Korean-based IT company specialized in providing mobile development solutions to the cosmetic and real-estate sectors. Having established in 2013, the company has released two products to the IT market. Glowmee is a beauty curation service that enables users to receive beauty and cosmetic related content via their mobile phones. The app provides information about latest products, product reviews, and recommendations on popular beauty brands available in the market. Glowmee also offers magazines and beauty box services to its subscribers. Brokery is a mobile app focused on the real-estate market. The app offers its users’ information about available accommodations facilities and connects them directly with brokers in the vicinity.

StyleShare

Venture Round in 2016
StyleShare Inc. is a mobile and web application developed for users to share and discover information related to fashion, beauty, and lifestyle. Founded in 2011 and based in Seoul, South Korea, the platform has attracted millions of users across 120 countries, establishing itself as a leading source for everyday fashion and beauty insights. Users can share their outfits, purchases, and receive updates, fostering a community centered around fashion discovery. StyleShare has received notable recognition from prominent publications such as VOGUE and Elle Japan, solidifying its status as a top mobile application in the fashion sector.

ABL Bio

Series A in 2016
ABL Bio Inc. is a South Korean biotech research company dedicated to developing therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company's pipeline includes ABL001, a bispecific antibody for cancer immunotherapy, and several antibody-drug conjugates (ADCs) such as ABL201-205. Additionally, ABL Bio is working on T cell engagers and dual immune cell targeting bispecific antibodies to enhance immuno-oncology treatments. Another notable product in development is ABL301, designed as a blood-brain barrier-penetrating bispecific antibody. The company emphasizes innovation and collaboration in its mission to improve lives through novel therapies.

Genome

Venture Round in 2016
Genome & Company is a biotechnology firm based in Seongnam, South Korea, focused on researching and developing products that harness the potential of the microbiome. The company specializes in the study of microbes and probiotics, aiming to create dietary supplements, cosmeceuticals, and new pharmaceuticals targeting conditions such as obesity, diabetes, acne, atopic dermatitis, and cancer. Through its innovative approach, Genome & Company seeks to advance health solutions that leverage the relationship between the microbiome and various health-related issues.

Pearl Abyss

Venture Round in 2016
Pearl Abyss Corp. is a South Korean game development studio founded in 2010 and headquartered in Anyang, near Seoul. The company is best known for creating Black Desert Online, a next-generation sandbox MMORPG that has garnered significant attention in the gaming community. In addition to game development, Pearl Abyss engages in game publishing, the development and sale of online game server and network engines, and provides related server and line services. The company is recognized for its talented and experienced team, contributing to its reputation in the gaming industry.

GDK Cosmetics

Private Equity Round in 2016
GDK Cosmetics is a cosmetic manufacturer based in Incheon, South Korea, specializing in the development and production of sheet mask products. The company offers a diverse range of cosmetics, including hand sanitizers, cleansers, masks and patches, sun care products, as well as body and hair care items and basic skincare solutions. GDK Cosmetics emphasizes sustainability and utilizes differentiated technology to ensure that its products are competitive in the market, catering to the evolving needs of consumers.

WeMakePrice

Venture Round in 2015
Wemakeprice Inc. is a South Korean social commerce platform founded in 2010 and based in Seoul. It operates an online shopping site, wemakeprice.com, which facilitates the buying and selling of a variety of products and services, including food, clothing, and merchandise. The platform connects merchants with consumers by offering goods and services at discounted prices, making them more accessible. In addition to e-commerce, Wemakeprice provides internet marketing and software development services. The company was previously known as Namu Internet Inc. before rebranding in 2013.

KoKomo Games

Series A in 2015
Kokomo Games is a gaming studio based in Seoul, South Korea, established in 2014. The company specializes in designing and developing massively multiplayer online role-playing games (MMORPGs). With a team of experienced professionals who have previously contributed to significant titles like "Lineage2" and "Blade&Soul," Kokomo aims to carve out a niche in the hardcore RPG genre, which they view as an untapped market. Unlike the current trend towards trading card games and midcore RPGs, Kokomo is focused on creating a flagship mobile MMORPG that appeals to gamers in Asia, particularly those with interests similar to the Korean gaming community. The studio's mission is to enhance the gaming experience by developing interactive, narrative-driven games that support multiplayer engagement in real-time.

The Beatpacking Company

Series B in 2015
The Beatpacking Company is a prominent provider of ad-supported music streaming services in South Korea, offering a mobile application known as BEAT. This platform allows users to access a diverse range of music tailored to their genre preferences, enhancing the listening experience through social features. By focusing on mobile devices and smartphones, The Beatpacking Company caters to the growing demand for music streaming in a mobile-centric environment, establishing itself as a leader in the South Korean music streaming market.

Krafton

Venture Round in 2014
Krafton Inc is a South Korean video game developer and holding company headquartered in Seongnam. It specializes in creating fantasy games for both PC and mobile platforms, and it is renowned for its popular title, PlayerUnknown's Battlegrounds. In addition to this flagship game, Krafton has developed several other titles, including PUBG: Battlegrounds, PUBG: New State, Tera, Elyon, and Mistover. The company aims to maintain its status as a leading name in the video game industry by adhering to its core value of craftsmanship in game development.

Woowa Bros

Series C in 2014
WOOWA BROS (우아한형제들) is a Korean developer of smartphone applications and advertising platforms. Its service portfolio also includes local marketing and web services solutions and products, such as a sports events app and a food delivery app. WOOWA BROS was established in March 2011 in Seoul, Korea.

Woowa Bros

Series A in 2012
WOOWA BROS (우아한형제들) is a Korean developer of smartphone applications and advertising platforms. Its service portfolio also includes local marketing and web services solutions and products, such as a sports events app and a food delivery app. WOOWA BROS was established in March 2011 in Seoul, Korea.

SJ Group

Venture Round in 2012
SJ Group is a South Korea-based clothing manufacturing firm that focuses on the production, wholesale, and retail of apparel and fashion accessories. The company operates in the garment industry, offering a range of products that cater to various consumer needs. By managing the entire supply chain from manufacturing to retail, SJ Group aims to provide high-quality clothing options to its customers.

Curaco

Venture Round in 2011
Curaco, Inc. is a South Korean company that specializes in developing an automatic toileting aid system designed for bedridden individuals. Founded in 2007 and based in Seongnam, the company has created a nursing bidet that utilizes built-in sensors to detect urine and feces. This system automatically flushes waste, rinses, and air-dries the user's body, offering a hygienic solution for seniors, disabled individuals, and patients with limited mobility. Curaco's products are targeted towards a range of facilities, including hospitals, hospices, nursing homes, and senior-care centers. The company emphasizes research and development, as well as training, to enhance the effectiveness and usability of its excretory care robots.

Mirae Cell Bio

Venture Round in 2010
Mirae Cell Bio Co., Ltd., founded in 2006 and based in Seoul, South Korea, specializes in stem cell remedies and animal biotechnology. The company focuses on developing advanced stem cell production technology aimed at creating products that combine natural ingredients with innovative technology. In addition to its work in the medical field, Mirae Cell Bio produces a diverse array of cosmetic products designed to enhance health and potentially improve the treatment of incurable diseases. Through its commitment to biotechnology, the company seeks to support medical professionals in promoting human health and well-being.

Point Mobile

Venture Round in 2010
Point Mobile is a manufacturer based in Seoul, Republic of Korea, specializing in enterprise handheld devices for corporate and industrial applications. Established in 2006, the company offers a diverse range of products, including rugged mobile computers, smartphones, LTE/Android integrated mobile payment devices, healthcare terminals, RFID readers, and portable Bluetooth scanners. In addition to its primary offerings, Point Mobile provides a variety of accessories, such as multi-slot cradles and vehicle chargers, to enhance the functionality of its devices.

Krafton

Venture Round in 2009
Krafton Inc is a South Korean video game developer and holding company headquartered in Seongnam. It specializes in creating fantasy games for both PC and mobile platforms, and it is renowned for its popular title, PlayerUnknown's Battlegrounds. In addition to this flagship game, Krafton has developed several other titles, including PUBG: Battlegrounds, PUBG: New State, Tera, Elyon, and Mistover. The company aims to maintain its status as a leading name in the video game industry by adhering to its core value of craftsmanship in game development.

Abion

Venture Round in 2009
Abion Inc. is a biotechnology company based in Seoul, South Korea, specializing in the development of chemical and biological drugs and vaccines. Founded in 2007, Abion focuses on advancing therapies for cancer and autoimmune diseases. Its portfolio includes several anticancer drug candidates, such as ABN401 for lung and stomach cancer, ABN501 as a biomarker for breast and ovarian cancers, and ABN201, a fusion protein designed to target cancer cells. Additionally, the company is developing ABN101, an interferon-beta based biological drug aimed at treating autoimmune diseases affecting the central nervous system. Abion also works on ABN701, a vaccine targeting staphylococcal enterotoxin B, and ABN601, a drug intended to protect the immune system from acute radiation syndrome.

Carver Korea

Venture Round in 2008
Carver Korea Co., Ltd., based in Seoul, South Korea, is a prominent cosmetics manufacturer known for its diverse range of products in skincare, make-up, and fashion. The company owns several brands, including A.H.C (Aesthetic Hydration Cosmetics), Shara Shara, and Vivito, as well as women's apparel under the brand Lenouvelle. Carver Korea's product offerings include eye creams, essences, toners, and other skincare essentials. These products are distributed through various channels such as home shopping television networks, retail stores, duty-free shops, beauty salons, skincare clinics, and e-commerce platforms, catering primarily to consumers in Korea. Since November 2017, Carver Korea has operated as a subsidiary of Unilever PLC.

i3system

Venture Round in 2006
i3system Inc. is a technology company based in Daejeon, South Korea, that specializes in the development, manufacturing, and sale of image sensors and X-ray detectors. Founded in 1998, the company produces a range of products, including cooled and uncooled infrared sensors and X-ray detectors for cephalometric and panoramic imaging. i3system serves various sectors, including defense, space, and medical, providing advanced imaging solutions tailored to the needs of these industries.

CU Medical Systems

Venture Round in 2005
CU Medical Systems, Inc. is a South Korean company that specializes in manufacturing and selling medical devices, particularly defibrillators, on a global scale. Founded in 2001 and headquartered in Wonju-si, the company offers a range of products, including automatic external defibrillators (AEDs), automated cardiopulmonary resuscitation systems, and healthcare and rehabilitation equipment. Additionally, CU Medical Systems provides AED trainers and sterilizers/disinfectors. The company also engages in the resale of Apple products, such as Mac computers and iPads. Its products are exported to various markets, including the United States and Africa.

DNA Link

Venture Round in 2004
DNA Link, Inc. is a biotechnology company based in Seoul, South Korea, specializing in genomic services and bio-industry research and development. The company offers a range of next-generation sequencing services, including De Novo, Exome, mRNA, small RNA, and whole genome sequencing, as well as target resequencing. Additionally, DNA Link provides analysis services for DNA, RNA, comparative genomic hybridization, and copy-number variations. The company is also involved in genotyping and bioinformatics services. Notably, DNA Link collaborates with BASE10 Genetics to assess the utility of the AccuFind COVID-19 IgG antibody test in healthcare settings. Founded in 2000, DNA Link aims to advance genomic analysis in Korea and beyond.

Gigalane

Venture Round in 2004
GigaLane Co., Ltd. is a South Korean company that specializes in the manufacturing and sale of semiconductor equipment and radio frequency (RF) components. The company offers a range of products, including DRIE etchers, ICP etchers, saw filter etchers, and nano imprinters, which are utilized in applications such as LED, MEMS, and power devices. GigaLane also produces RF connectors, cables, and antenna modules, providing advanced solutions for 5G mobile communication and serving military and aerospace markets that require high reliability. In addition to its manufacturing capabilities, GigaLane engages in the trading of semiconductor equipment and offers test solutions, including probe cards and automated manufacturing equipment. The company has expanded its offerings to include Internet of Things solutions, featuring hardware and software products focused on location monitoring and safety. Founded in 2000 and headquartered in Hwaseong, GigaLane operates a global R&D and manufacturing network to ensure quality service and cost efficiency.

GITSN

Venture Round in 2004
GITSN, Inc. is a security technology company based in Seoul, South Korea, that specializes in developing solutions to detect eavesdropping and illegal surveillance. Founded in 2000 and formerly known as HANNETWARE, Inc., the company offers a range of products, including the REMON-10, a 24/7 eavesdropping detection system; ALPHA-S, a digital illegal eavesdropping detection system; and PRISM, a portable hand-held detection device. GITSN also focuses on wireless hacking detection systems and has created technology to guard against high-tech security threats such as eavesdropping and unauthorized photography. Through its innovative solutions, GITSN aims to protect individuals and organizations from potential security breaches.

ICTK Co.

Venture Round in 2003
ICTK Co., Ltd., founded in 2001 and headquartered in Seongnam-si, South Korea, specializes in payment testing and certification services for mobile devices, payment cards, and point of sale terminals. The company is an accredited international testing laboratory for several industry standards, including EMVCo, Visa, JCB, Discover, Global Platform, and the NFC Forum. ICTK offers high-quality engineering services for smart cards, mobile devices, and terminals. Additionally, its Security R&D Division has developed a range of PUF (Physical Unclonable Functions)-based security chips and solutions, holding over 80 patents and licenses since 2006. ICTK is poised to launch innovative PUF-based solutions in collaboration with a prominent automobile group. As of December 2017, ICTK operates as a subsidiary of Bureau Veritas SA.

ToolGen

Venture Round in 2003
ToolGen is a biotechnology company based in Seoul, South Korea, established in 1999, that specializes in genome editing technology. The company develops a range of products, including purified gRNA/Cas9 reagents, gRNA/Cas9 plasmids, and recombinant Cas9 proteins, which are designed for genome engineering experiments. In addition to these products, ToolGen provides services such as the creation of genome-edited cell lines, mice, rats, and plants, as well as surrogate reporter synthesis and in-del analysis services. These offerings support various research applications in the field of biotechnology. ToolGen operates as a subsidiary of NSN.

Yest

Venture Round in 2003
Yest produces semiconductors, LED, AMOLED, and LCD display components, as well as materials. Founded in 2000 and is based in Pyongtaek, Kyonggi-do, South Korea.

Osstem

Venture Round in 2003
Osstem develops and produces dental implants for dental treatment featuring dental equipment. They develop 3D printing and milling materials which are core materials of digital dentistry and repair materials. They provide total solutions for dental treatment featuring dental equipment, materials, and pharmaceutical products. Their development and sales of medical equipment including unit chairs, CTS, and panorama imaging devices.

DiNonA

Venture Round in 2001
DiNonA is a biotechnology company based in Seoul, South Korea, focused on the research and development of antibody-related therapeutics and diagnostic reagents. The company aims to advance healthcare solutions through innovative antibody drug development, addressing various medical needs. By leveraging expertise in antibody technologies, DiNonA is committed to creating effective therapeutic options and diagnostic tools that can enhance patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.